Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

NCT01676649 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Untreated Stage III Melanoma or Stage IV Melanoma

Interventions

BIOLOGICAL: Ipilimumab
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Jewish General Hospital